Neuralink's First Patient Says Brain Chip Changed His Life at Dubai Summit

First Neuralink Recipient Speaks at World Government Summit

Noland Arbaugh, the first person to receive a brain-computer interface implant from Elon Musk's Neuralink, addressed global leaders at the World Government Summit in Dubai on February 4, 2026. The 31-year-old, who has been paralysed from the shoulders down since a swimming accident in 2016, described how the technology has fundamentally changed his life.

How the Implant Works

Arbaugh received Neuralink's N1 implant on January 28, 2024, at Barrow Neurological Institute in Phoenix. The device uses 64 ultra-thin threads containing 1,024 electrodes implanted in the motor cortex. It captures neural signals and transmits them wirelessly via Bluetooth to external devices, allowing users to control computers through thought alone. Arbaugh uses the system approximately ten hours daily to play video games, browse the internet, send emails, and operate devices.

A New Chapter of Independence

Since receiving the implant, Arbaugh has enrolled at a community college in Arizona to pursue prerequisites for a neuroscience degree. He has also launched a professional speaking business and travelled extensively, including trips to Paris and now Dubai. When first given full control of the device, he played a video game for eight hours straight, something he hadn't been able to do for eight years.

Neuralink's Growing Clinical Programme

Arbaugh's appearance comes as Neuralink announced it now has 21 participants enrolled in clinical trials worldwide, up from 12 reported in late 2025. The company reports zero serious device-related adverse events, with signal quality improving in 18 of the 20 most recent cases. Participants have reached typing speeds of 40 words per minute using imagined finger movements.

What Comes Next

Neuralink plans to begin high-volume production of its devices in 2026 and transition to nearly fully automated surgical procedures. The company is also preparing to test its Blindsight device, designed to restore vision, in its first human patient this year. A next-generation implant with three times the electrode count is planned for the coming months. Trials are expanding globally, including sites in Canada, the United Kingdom, and the United Arab Emirates.